Ostrum Asset Management’s Elevance Health ELV Stock Holding History

Ostrum Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.16M	Sell	7,365 -613	-8%	-$201K	0.12%	133
2025 Q4	$2.8M	Sell	7,978 -1,529	-16%	-$517K	0.13%	122
2025 Q3	$3.07M	Sell	9,507 -6,673	-41%	-$2.08M	0.14%	135
2025 Q2	$6.29M	Buy	16,180 +5,340	+49%	+$2.15M	0.29%	56
2025 Q1	$4.71M	Buy	10,840 +6	+0.1%	+$2.41K	0.25%	66
2024 Q4	$4M	Sell	10,834 -320	-3%	-$134K	0.35%	67
2024 Q3	$5.8M	Sell	11,154 -210	-2%	-$112K	0.48%	38
2024 Q2	$6.16M	Sell	11,364 -1,110	-9%	-$587K	0.54%	30
2024 Q1	$6.47M	Buy	12,474 +523	+4%	+$260K	0.51%	27
2023 Q4	$5.64M	Sell	11,951 -272	-2%	-$126K	0.49%	38
2023 Q3	$5.32M	Sell	12,223 -29	-0.2%	-$13.2K	0.49%	33
2023 Q2	$5.44M	Sell	12,252 -216	-2%	-$99.6K	0.46%	47
2023 Q1	$5.73M	Buy	+12,468	New	+$5.93M	0.5%	37

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Ostrum Asset Management's ELV Position: Q1 2026 in Review

Ostrum Asset Management reduced its Elevance Health (ELV) stake by 7.7% in Q1 2026, selling an estimated $201K and leaving 7,365 shares worth $2.16M. The position accounts for 0.12% of the portfolio, ranked #133.

Ostrum Asset Management first reported a position in ELV in Q1 2023 and has held it in 13 quarters since. The position peaked at $6.47M in Q1 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Ostrum Asset Management held 7,365 shares of Elevance Health worth $2.16M as of Q1 2026.
Ostrum Asset Management sold 613 Elevance Health shares in Q1 2026, an estimated $201K.
Elevance Health made up 0.12% of Ostrum Asset Management's portfolio in Q1 2026, its #133 holding.
Ostrum Asset Management first reported a position in Elevance Health in Q1 2023 and has held it in 13 quarters since.
Ostrum Asset Management's Elevance Health position peaked at $6.47M in Q1 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.